chlorambucil has been researched along with hydroxychloroquine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Ingrao, S; Larsen, G; Maceira, A; Macor, P; Mansilla, E; Marín, GH; Mertz, C; Mezzaroba, N; Núñez, L; Spretz, R; Tau, JM; Tedesco, F; Tripodo, C; Zorzet, S | 1 |
Baj, G; Biffi, S; Calvaruso, M; Capolla, S; Garrovo, C; Gattei, V; Granzotto, M; Larsen, G; Lucafò, M; Macor, P; Mansilla, E; Marín, GH; Mendoza-Maldonado, R; Mezzaroba, N; Noriega, S; Núñez, L; Pozzato, G; Secco, E; Spretz, R; Tripodo, C; Zorzet, S | 1 |
1 review(s) available for chlorambucil and hydroxychloroquine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for chlorambucil and hydroxychloroquine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
[Corticotherapy in rheumatoid polyarthritis].
Topics: Adrenocorticotropic Hormone; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Betamethasone; Chlorambucil; Cortisone; Dexamethasone; Diabetes Mellitus; Female; Gastrointestinal Diseases; Glucocorticoids; Gold; Humans; Hydroxychloroquine; Hypertension; Male; Methylprednisolone; Middle Aged; Paramethasone; Prednisolone; Prednisone; Triamcinolone | 1971 |
Exploratory study on the effects of biodegradable nanoparticles with drugs on malignant B cells and on a human/mouse model of Burkitt lymphoma.
Topics: Animals; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; B-Lymphocytes; Burkitt Lymphoma; Cell Survival; Chlorambucil; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Humans; Hydroxychloroquine; Mice; Mice, Inbred C57BL; Nanoparticles; Rituximab; Tumor Cells, Cultured | 2010 |
New potential therapeutic approach for the treatment of B-Cell malignancies using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles.
Topics: Animals; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Apoptosis; Autophagy; Cell Survival; Chlorambucil; Disease Models, Animal; Drug Combinations; Drug Delivery Systems; Female; Flow Cytometry; Hydroxychloroquine; Immunohistochemistry; Lymphoma, B-Cell; Mice; Mice, SCID; Microscopy, Electron, Transmission; Nanoparticles; Rituximab | 2013 |